T1	Eq-Comparison 42 45	≥ 3
E1	Eq-Comparison:T1 Operator:T50 Value:T51
T2	Age 64 67	age
E2	Age:T2 Eq-Comparison:E1 Eq-Comparison2:E50
T3	Observation 78 96	predicted survival
E3	Observation:T3 Name:T100 Eq-Comparison:E4
T4	Eq-Comparison 107 125	more than 3 months
E4	Eq-Comparison:T4 Operator:T55 Value:T56 Temporal-Unit:T57
T5	Eq-Comparison 174 186	at least one
E5	Eq-Comparison:T5 Operator:T58 Value:T59
T6	Condition 198 204	lesion
E6	Condition:T6 Name:T60 Minimum-Count:E5
T7	Temporal-Connection 211 215	Post
E7	Temporal-Connection:T7 Arg:E52 Arg2:E8
A1	Temporal-Connection-Type-Value E7 after
T8	Condition 225 243	pathological stage
E8	Condition:T8 Name:T61 Stage:E9
T9	Eq-Comparison 248 259	group II-IV
E9	Eq-Comparison:T9 Value:T63 Operator:T64 Value:T65 Unit:T102
T10	Negation 280 283	not
E10	Negation:T10 Negates:E12
T11	Eq-Comparison 284 292	received
E11	Eq-Comparison:T11 Temporal-Period:T66
T12	Procedure 293 305	radiotherapy
E12	Procedure:T12 Name:T67 Temporality:E11 Temporality2:E13
T14	And 314 317	and
E14	And:T14 Arg:E10 Arg2:E15
T15	Assertion 318 328	can accept
E15	Assertion:T15 Asserted:E16 Asserted2:E18
A3	Assertion-Type-Value E15 hypothetical
T16	Procedure 329 341	chemotherapy
E16	Procedure:T16 Name:T68
T17	Or 342 345	and
E17	Or:T17 Arg:E16 Arg2:E18
T18	Procedure 346 364	surgical treatment
E18	Procedure:T18 Name:T69
T19	Negation 371 373	No
E19	Negation:T19 Negates:E21
T20	Other 374 379	other
E20	Other:T20 Is-Other:E21
T21	Procedure 380 398	anticancer therapy
E21	Procedure:T21 Name:T70
T22	Assertion 399 408	should be
E22	Assertion:T22 Asserted:E21
A4	Assertion-Type-Value E22 hypothetical
T23	Temporal-Connection 414 420	during
E23	Temporal-Connection:T23 Arg:E21 Arg2:E24
A5	Temporal-Connection-Type-Value E23 during
T24	Procedure 421 433	radiotherapy
E24	Procedure:T24 Name:T71
T25	Condition 444 455	main organs
E25	Condition:T25 Name:T104 Polarity:T105
T26	Procedure 528 553	Blood routine examination
E26	Procedure:T26 Name:T72
T27	Negation 580 582	no
E27	Negation:T27 Negates:E28
T29	Eq-Comparison 601 615	within 14 days
E29	Eq-Comparison:T29 Operator:T74 Value:T30 Temporal-Unit:T31
T50	Eq-Operator 42 43	≥
A7	Eq-Operator-Value T50 GTEQ
T51	Eq-Value 44 45	3
T52	Eq-Operator 50 51	≤
A8	Eq-Operator-Value T52 LTEQ
T53	Eq-Value 52 54	18
T54	Eq-Temporal-Unit 55 60	years
A9	Eq-Temporal-Unit-Value T54 year
T55	Eq-Operator 107 116	more than
A10	Eq-Operator-Value T55 GT
T56	Eq-Value 117 118	3
T57	Eq-Temporal-Unit 119 125	months
A11	Eq-Temporal-Unit-Value T57 month
T58	Eq-Operator 174 182	at least
A12	Eq-Operator-Value T58 GTEQ
T59	Eq-Value 183 186	one
T60	Condition-Name 198 204	lesion
T61	Condition-Name 225 243	pathological stage
T63	Eq-Value 254 256	II
T64	Eq-Operator 256 257	-
A13	Eq-Operator-Value T64 BETWEEN
T65	Eq-Value 257 259	IV
T66	Eq-Temporal-Period 284 292	received
A14	Eq-Temporal-Period-Value T66 past
T67	Procedure-Name 293 305	radiotherapy
T68	Procedure-Name 329 341	chemotherapy
T69	Procedure-Name 346 364	surgical treatment
T70	Procedure-Name 380 398	anticancer therapy
T71	Procedure-Name 421 433	radiotherapy
T72	Procedure-Name 528 553	Blood routine examination
T74	Eq-Operator 601 607	within
A16	Eq-Operator-Value T74 LTEQ
T98	Eq-Comparison 50 60	≤ 18 years
E50	Eq-Comparison:T98 Operator:T52 Value:T53 Temporal-Unit:T54
T99	And 46 49	and
E51	And:T99 Arg:E1 Arg2:E50
T100	Observation-Name 78 96	predicted survival
T62	Procedure 215 224	operative
E52	Procedure:T62 Name:T101
T101	Procedure-Name 215 224	operative
T102	Eq-Unit 248 253	group
T13	Eq-Comparison 306 312	before
E13	Eq-Comparison:T13 Temporal-Period:T103
T103	Eq-Temporal-Period 306 312	before
A2	Eq-Temporal-Period-Value T103 past
T104	Condition-Name 444 455	main organs
T105	Polarity 472 480	normally
A29	Polarity-Value T105 normal
T106	Criteria-Count 494 516	the following criteria
E53	Criteria-Count:T106 Criteria:E26 Criteria2:E30 Criteria3:E32 Criteria4:E35
R2	Equivalent-To Arg1:E53 Arg2:E25	
T30	Eq-Value 608 610	14
T31	Eq-Temporal-Unit 611 615	days
A6	Eq-Temporal-Unit-Value T31 day
T28	Procedure 583 600	blood transfusion
E28	Procedure:T28 Name:T32 Temporality:E29
T32	Procedure-Name 583 600	blood transfusion
R3	Equivalent-To Arg1:E27 Arg2:E26	
T33	Observation 620 622	HB
E30	Observation:T33 Name:T34 Eq-Comparison:E31
T34	Observation-Name 620 622	HB
A15	Observation-Type-Value T34 lab
T35	Eq-Comparison 623 631	> 90 g/L
E31	Eq-Comparison:T35 Operator:T36 Value:T37 Unit:T38 Per:T39
T36	Eq-Operator 623 624	>
A17	Eq-Operator-Value T36 GT
T37	Eq-Value 625 627	90
T38	Eq-Unit 628 629	g
T39	Eq-Unit 630 631	L
T40	Observation 636 639	ANC
E32	Observation:T40 Name:T41 Eq-Comparison:E33
T41	Observation-Name 636 639	ANC
A18	Observation-Type-Value T41 lab
T42	Eq-Comparison 640 653	> 1.5 * 109/L
E33	Eq-Comparison:T42 Value:T44 Value2:T45 Operator:T43 Per:T46
T43	Eq-Operator 640 641	>
A19	Eq-Operator-Value T43 GT
T44	Eq-Value 642 645	1.5
T45	Eq-Value 648 651	109
T46	Eq-Unit 652 653	L
T47	Eq-Comparison 662 675	> 80 * 109 /L
E34	Eq-Comparison:T47 Operator:T73 Value:T75 Value2:T76 Per:T77
T48	Observation 658 661	PLT
E35	Observation:T48 Name:T49 Eq-Comparison:E34
T49	Observation-Name 658 661	PLT
A20	Observation-Type-Value T49 lab
T73	Eq-Operator 662 663	>
A21	Eq-Operator-Value T73 GT
T75	Eq-Value 664 666	80
T76	Eq-Value 669 672	109
T77	Eq-Unit 674 675	L
T78	Observation 686 703	Biochemical tests
E36	Observation:T78 Name:T79
T79	Observation-Name 686 703	Biochemical tests
A22	Observation-Type-Value T79 lab
T80	Criteria-Count 716 738	the following criteria
E37	Criteria-Count:T80 Criteria:E38 Criteria2:E40 Criteria3:E41 Criteria4:E44 Criteria5:E46
R4	Equivalent-To Arg1:E37 Arg2:E36	
T81	Observation 743 746	BIL
E38	Observation:T81 Name:T82 Eq-Comparison:E39
T82	Observation-Name 743 746	BIL
A23	Observation-Type-Value T82 lab
T83	Eq-Comparison 747 784	< 1.25 times normal upper limit (ULN)
E39	Eq-Comparison:T83 Operator:T84 Value:T85 Unit:T86 Unit2:T87
T84	Eq-Operator 747 748	<
A24	Eq-Operator-Value T84 LT
T85	Eq-Value 749 753	1.25
T86	Eq-Unit 760 778	normal upper limit
A25	Eq-Unit-Value T86 ref-range-normal
T87	Eq-Unit 780 783	ULN
A26	Eq-Unit-Value T87 ref-range-normal
R5	Abbrev-Of Arg1:T87 Arg2:T86	
T88	Observation 789 792	ALT
E40	Observation:T88 Name:T89 Eq-Comparison:E43
T89	Observation-Name 789 792	ALT
A27	Observation-Type-Value T89 lab
T90	Observation 797 800	AST
E41	Observation:T90 Name:T91 Eq-Comparison:E43
T91	Observation-Name 797 800	AST
A28	Observation-Type-Value T91 lab
T92	And 793 796	and
E42	And:T92 Arg:E40 Arg2:E41
T93	Eq-Comparison 801 810	< 2.5 ULN
E43	Eq-Comparison:T93 Operator:T94 Unit:T96 Value:T95
T94	Eq-Operator 801 802	<
A30	Eq-Operator-Value T94 LT
T95	Eq-Value 803 806	2.5
T96	Eq-Unit 807 810	ULN
A31	Eq-Unit-Value T96 ref-range-normal
T97	Observation 815 823	Serum Cr
E44	Observation:T97 Name:T107 Eq-Comparison:E45
T107	Observation-Name 815 823	Serum Cr
A32	Observation-Type-Value T107 lab
T108	Eq-Comparison 824 831	< 1 ULN
E45	Eq-Comparison:T108 Operator:T109 Value:T110 Unit:T111
T109	Eq-Operator 824 825	<
A33	Eq-Operator-Value T109 LT
T110	Eq-Value 826 827	1
T111	Eq-Unit 828 831	ULN
A34	Eq-Unit-Value T111 ref-range-normal
T112	Observation 833 864	endogenous creatinine clearance
E46	Observation:T112 Name:T113 Eq-Comparison:E47
T113	Observation-Name 833 864	endogenous creatinine clearance
A35	Observation-Type-Value T113 lab
T114	Eq-Comparison 865 876	> 50 ml/min
E47	Eq-Comparison:T114 Operator:T115 Value:T116 Unit:T117 Per:T118
T115	Eq-Operator 865 866	>
A36	Eq-Operator-Value T115 GT
T116	Eq-Value 867 869	50
T117	Eq-Unit 870 872	ml
T118	Eq-Temporal-Unit 873 876	min
A37	Eq-Temporal-Unit-Value T118 minute
